MedPath

Proper Extent of Maze Intercaval Lesion

Withdrawn
Conditions
Atrial Fibrillation
Registration Number
NCT03091205
Lead Sponsor
Baylor Research Institute
Brief Summary

It's hypothesized that a mean and range distance from the cavo-atrial junction to the area where there is complete loss of conductive tissue can be measured to better inform surgeons performing the Cox-Maze procedure. A patient scheduled for any cardiac surgery where visualization and mapping of cavo-atrial junction is possible could be entered into the study if they meet the inclusion/exclusion requirements.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Age β‰₯ 18 years male or female
  • Scheduled for any cardiac surgery where visualization and mapping of cavo-atrial junction is possible
  • Subjects willing and able to provide written informed consent
Exclusion Criteria
  • Subjects receiving surgery with non-sternotomy access
  • Presence of or history of transvenous pacing leads
  • Subjects receiving a re-do cardiac surgery
  • Subjects with a history of pericarditis
  • Subjects who are in atrial fibrillation or atrial flutter and cannot be converted out of it.
  • Any medical condition or finding for which the Investigator used medical discretion to determine the subject should be excluded
  • Subject is currently participating in another clinical trial.
  • Subject is unable to provide written informed consent.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Distance until complete loss of conductive tissue6 Months

To measure the mean and range distance from the cavo-atrial junction to the area where there is complete loss of conductive tissue.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The Heart Hospital Baylor Plano

πŸ‡ΊπŸ‡Έ

Plano, Texas, United States

The Heart Hospital Baylor Plano
πŸ‡ΊπŸ‡ΈPlano, Texas, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.